Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?

por Müller, Ebba Gløersen, Edwin, Trine Holt, Strand, Bjørn Heine, Stokke, Caroline, Revheim, Mona Elisabeth, Knapskog, Anne-Brita
Publicado 2022

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

por Müller, Ebba Gløersen, Edwin, Trine Holt, Stokke, Caroline, Navelsaker, Sigrid Stensby, Babovic, Almira, Bogdanovic, Nenad, Knapskog, Anne Brita, Revheim, Mona Elisabeth
Publicado 2019

No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

por Hagberg, Guri, Ihle-Hansen, Hege, Fure, Brynjar, Thommessen, Bente, Ihle-Hansen, Håkon, Øksengård, Anne Rita, Beyer, Mona K., Wyller, Torgeir B., Müller, Ebba Gløersen, Pendlebury, Sarah T., Selnes, Per
Publicado 2020